世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

生物学的特異性mAbSの世界市場2032年までの機会と戦略Including1) タイプ別タイプ別:Catumaxomab (Removab); Blinatumomab; Emicizumab; Amivantamab; Faricimab; Teclistamab2)適応症別:がん; 血友病A; 眼科3)エンドユース別:病院3)2032年までの世界市場機会・戦略癌、血友病A、眼科3) エンドユース別:病院、研究機関Covering:F.ホフマン・ラ・ロシュ;アムジェン;ジョンソン・エンド・ジョンソン


BiSpecific mAbS Global Market Opportunities And Strategies To 2032Including: 1) By Type: Catumaxomab (Removab); Blinatumomab; Emicizumab; Amivantamab; Faricimab; Teclistamab2) By Indication: Cancer; Hemophilia A; Ophthalmic3) By End Use: Hospitals; Research InstitutesCovering: F. Hoffmann-La Roche AG; Amgen Inc; Johnson & Johnson

この調査レポートは、2032年までの二特異性mAbSの世界市場のビジネスチャンスと戦略について調査・分析した結果を掲載したビジネス調査報告書です。 購入の理由 - 12地域をカバーするこの市場に関する最も包... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
The Business Research Company (TBRC)
ザ・ビジネスリサーチカンパニー
2023年4月25日 US$5,000
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
275 英語

 

サマリー

この調査レポートは、2032年までの二特異性mAbSの世界市場のビジネスチャンスと戦略について調査・分析した結果を掲載したビジネス調査報告書です。

購入の理由
- 12地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができる。
- 市場がコロナウイルスからどのような影響を受けているのか、また、ウイルスの影響が和らぐにつれて市場がどのように立ち上がり、成長していくのかを理解することができます。
- 現地のデータと分析に基づき、地域別および国別の戦略を策定します。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成するドライバーとトレンドを活用し、競合他社を凌駕する。
- 最新の市場調査結果に基づいて顧客を理解する。
- 主要な競合他社とのパフォーマンスの比較
- 主要データセット間の関係を活用し、優れた戦略を立てる。
- 信頼性の高い高品質なデータと分析により、社内外のプレゼンテーションをサポートします。


説明
二重特異性mAbSの最大かつ急成長市場はどこか?経済全体、人口動態、他の類似市場との関連は?今後の市場を形成する力は何か?ビジネスリサーチ社の二重特異性mAbS市場に関する調査レポート「二重特異性mAbSの世界市場」は、これらすべての疑問やその他多くの疑問にお答えします。
当レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、市場の動向と戦略について解説しています。市場の歴史をたどり、地域別の市場成長を予測しています。また、二重特異性mAbS市場全体の中で同市場を位置づけ、他市場との比較も行っています。

本レポートは以下の章をカバーしています。
- 序論と市場の特徴
市場細分化、定義、二重特異性mAbs市場についての簡単な紹介。
- 主要動向
世界の二重特異性mAbs市場を形成している主要トレンドをハイライトしています。また、同市場における今後の展開についても取り上げます。
- 世界の市場規模と成長
世界の過去(2017年~2022年)および予測(2022年~2027年)、(2027年~2032年)の市場価値、過去および予測期間における市場の成長を支え、制御する促進因子および阻害因子を紹介します。
- 地域別分析
地域別の過去(2017-2022年)および予測(2022-2027年)、(2027-2032年)市場価値と成長率、市場シェア比較。
- 市場セグメンテーション
市場におけるタイプ別、適応症別、エンドユース別の市場価値(2017-2032年)と各セグメントの分析を収録。
- 地域別市場規模と成長
地域別の市場規模(2022年)、過去(2017年~2022年)および予測(2022年~2027年)、(2027年~2032年)の市場価値、地域内各国の成長率および市場シェア比較を掲載。本レポートには、アジア太平洋、西欧、東欧、北米、南米、中東、アフリカの全地域と各地域内の主要国に関する情報が含まれています。
- 競争環境
市場の競争状況、推定市場占有率、主要企業の会社プロファイルの詳細を掲載しています。
- 主要なM&A
本レポートでカバーしている市場における最近のM&Aに関する情報を掲載しています。近年の市場を形成したM&Aに関する主要な財務情報を掲載しています。
- 市場機会と戦略
調査結果に基づく市場機会と戦略を掲載しています。このセクションでは、国やセグメントごとの成長機会や、それらの市場で取るべき戦略に関する情報も提供します。今後5年間に競合他社が大きなビジネスを獲得できる可能性のある市場について理解することができる。
- 結論と提言
本セクションには、調査結果に基づく結論と提言が含まれる。また、製品・サービスの提供、地理的拡大、マーケティング戦略、ターゲットグループなどの観点から、二重特異性mAbSプロバイダーに対する提言も行う。
- 付録
このセクションには、本レポートで使用したNAICSコード、略語、通貨コードの詳細が含まれています。

スコープ

対象市場

1) タイプ別カツマキソマブ(リムーブマブ™);ブリナツモマブ;エミシズマブ;アミバンタマブ;ファリシマブ;テクリスタマブ
2)適応症別癌、血友病A、眼科
3) エンドユーザー別:病院、研究機関、その他

言及された企業F.ホフマン・ラ・ロシュ;アムジェン;ジョンソン・エンド・ジョンソン

国別中国、オーストラリア、インド、インドネシア、日本、韓国、米国、ブラジル、フランス、ドイツ、英国、ロシア

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列:過去5年間および過去10年間の予測。

データデータ:市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、二種特異的mAbS指標の比較。

データ区分:国・地域の過去および予測データ、競合他社の市場シェア、市場セグメント。

ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。



当レポートでは、二重特異性mAbs市場について記載・解説し、2017-2022年を過去期間、2022-2027年を予測期間とし、2027-2032年のさらなる予測を加えています。本レポートでは、各地域および各地域内の主要経済圏の市場を評価しています。

世界の二重特異性mAbs市場は、2017年以降年平均成長率(CAGR)69.9%で成長し、2022年には約44億6,240万ドルに達した。市場は2022年の44億6,240万ドルから2027年には118億1,100万ドルに21.5%の成長率で拡大すると予想される。その後、2027年からCAGR13.5%で成長し、2032年には222億5,590万ドルに達すると予想される。

歴史的な期間の成長は、医療費の増加、資金調達の増加、政府の取り組みによるものである。

今後は、癌の有病率の増加、高齢化人口の増加、慢性疾患の有病率の増加が市場成長の原動力となるだろう。将来の二重特異性mAbs市場の成長を阻害する要因としては、ロシア・ウクライナ戦争や、癌に対する様々な代替治療法の利用可能性などが挙げられる。

二重特異性mAbs市場はタイプ別にブリナツモマブ、エミシズマブ、アミバンタマブ・ファリシマブ、テクリスタマブに区分される。エミシズマブ市場は、2022年に全体の86.6%を占める二重特異性mAbs市場の最大セグメントである。今後、アミバンタマブ市場は、タイプ別に区分された二重特異性mAbs市場において最も急成長するセグメントとなり、2022〜2027年のCAGRは44.8%となる見込みである。

二重特異性mAbs市場は適応症別にがん、血友病A、眼科に区分される。血友病A市場は、2022年に全体の86.6%を占める適応症別二特異性mAbs市場の最大セグメントであった。今後、眼科市場は適応症別二特異性mAbs市場において最も急成長するセグメントであり、2022〜2027年のCAGRは46.5%と予想される。

二重特異性mAbs市場は、最終用途別に病院、研究機関、その他のエンドユーザーに区分される。病院市場は、エンドユーザー別にセグメント化された二重特異性mAbs市場の最大セグメントで、2022年には全体の65.5%を占めた。今後、病院市場はエンドユーザー別に区分された二重特異性mAbs市場で最も急成長するセグメントとなり、2022〜2027年のCAGRは21.9%になると予想される。

二重特異性mAbs市場で最大の地域は北米で、2022年には全体の62.6%を占めた。次いで西欧、アジア太平洋、その他の地域と続く。今後、二重特異性mAbs市場で最も急速に成長する地域は西欧とアジア太平洋で、それぞれCAGR17.2%と11.5%で成長する。これに続くのは中東と南米で、それぞれCAGR4.2%と2.0%の成長が見込まれる。

世界の二重特異性mAbs市場は非常に集中しており、少数の大手企業が市場の大半を占めている。2021年には競合3社で市場の100%を占めている。最近の技術革新が各社の市場プレゼンス強化に貢献している。F.ホフマン・ラ・ロシュAGが市場シェア85.74%で最大手、アムジェンIncが13.45%、ジョンソン・エンド・ジョンソンが0.81%である。

二重特異性mAbs市場をタイプ別にセグメント化すると、エミシズマブ(emicizumab)セグメントに大きなビジネスチャンスがあり、2027年までに世界全体の年間売上高が58億6,830万ドルに達すると予想される。適応症別では、2027年までに58億6830万ドルの世界年間売上高を獲得する血友病Aセグメントで最大のビジネスチャンスが生まれるだろう。エンドユース別では、2027年までに世界全体の年間売上高が49億3,880万ドルに達する病院セグメントで最大のビジネスチャンスが見込まれる。二重特異性mAbsの市場規模は米国で最も大きく、34億8,340万ドルである。

二重特異性mAbs市場の市場トレンドに基づく戦略には、技術的進歩への注力、製品革新、人工知能への注力、標的治療と併用療法への投資、戦略的パートナーシップなどがある。

二重特異性mAbs市場におけるプレーヤー採用戦略には、薬事承認取得による事業強化、戦略的買収による事業能力強化、薬事承認取得による事業強化への注力などが含まれる。

ビジネス・リサーチ・カンパニーは、この機会を活用するために、二重特異性mAbs企業に対し、人工知能への注力、製品イノベーションへの注力、標的治療および併用療法への投資への注力、技術進歩への注力、新興市場での拡大、先進国市場への継続的な注力、研究インセンティブを提供する国での拡大、戦略的パートナーシップへの注力、競争力のある価格での提供、展示会やイベントへの参加、B2Bプロモーションの継続利用、急成長するエンドユーザーへの継続的なターゲット設定、高齢化人口へのターゲット設定を推奨している。


ページTOPに戻る


目次

1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. BiSpecific mAbs Market Definition and Segmentations
6.4. Market Segmentation By Type
6.4.1. Catumaxomab (Removab™)
6.4.2. Blinatumomab
6.4.3. Emicizumab
6.4.4. Amivantamab
6.4.5. Faricimab
6.4.6. Teclistamab
6.5. Market Segmentation By Indication
6.5.1. Cancer
6.5.2. Haemophilia A
6.5.3. Ophthalmic
6.6. Market Segmentation By End Use
6.6.1. Hospitals
6.6.2. Research Institutes
6.6.3. Other End-Users
7. Major Market Trends
7.1. Technological Advancements
7.2. Product Innovation
7.3. Focus On Artificial Intelligence
7.4. Investment in Targeted and Combination Therapy
7.5. Strategic Partnerships
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
8.2.1. Market Drivers 2017 – 2022
8.2.2. Market Restraints 2017 – 2022
8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 – 2027
8.3.2. Market Restraints 2022 – 2027
9. Global BiSpecific mAbS Market Segmentation
9.1. Global BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.2. Global BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.3. Global BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. BiSpecific mAbS Market, Regional and Country Analysis
10.1. Global BiSpecific mAbS Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.2. Global BiSpecific mAbS Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.4. Asia-Pacific BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.5. Asia-Pacific BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific BiSpecific mAbS Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes levied
11.11.9. Corporate tax structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.13. China BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.14. China BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.15. China BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.16. China BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.19. India BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.20. India BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.21. India BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.22. India BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.25. Japan BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.26. Japan BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.31. Australia BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.32. Australia BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.37. Indonesia BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.38. Indonesia BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.43. South Korea BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.44. South Korea BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes levied
12.2.9. Corporate tax structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.4. Western Europe BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.5. Western Europe BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe BiSpecific mAbS Market: Country Analysis
12.9. UK Market
12.10. UK BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.11. UK BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.12. UK BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.13. UK BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.14. UK BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.17. Germany BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.18. Germany BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.23. France BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.24. France BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.25. France BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.26. France BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.4. Eastern Europe BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.5. Eastern Europe BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe BiSpecific mAbS Market: Country Analysis
13.9. Russia Market
13.10. Russia BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.11. Russia BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.12. Russia BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.4. North America BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.5. North America BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.6. North America BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.7. North America BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.8. North America BiSpecific mAbS Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.13. USA BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.14. USA BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.15. USA BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.16. USA BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.4. South America BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.5. South America BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.6. South America BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.7. South America BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.8. South America BiSpecific mAbs Market: Country Analysis
15.9. Brazil Market
15.10. Brazil BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.11. Brazil BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.12. Brazil BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.4. Middle East BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.5. Middle East BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
17.4. Africa BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
17.5. Africa BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape and Company Profiles
19. Company Profiles
19.1. F. Hoffmann-La Roche AG
19.1.1. Company Overview
19.1.2. Products And Services
19.1.3. Business Strategy
19.1.4. Financial Overview
19.2. Amgen Inc
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. Johnson & Johnson
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
20. Key Mergers and Acquisitions
20.1. invoX Pharma Acquired F-Star Therapeutics, Inc.
20.2. Amgen Acquired TeneoBio
20.3. Sanofi Acquired Kymab Group Ltd.
20.4. AbCellera Acquired OrthoMab Bispecific Platform
20.5. True North Acquired Stake In Biocon Biologics
21. Opportunities And Strategies
21.1. Global BiSpecific mAbS Market In 2027 – Countries Offering Most New Opportunities
21.2. Global BiSpecific mAbS Market In 2027 – Segments Offering Most New Opportunities
21.3. Global BiSpecific mAbS Market In 2027 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Bi-Specific mAbs Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. The Business Research Company
23.5. Copyright and Disclaimer

 

ページTOPに戻る


 

Summary

BiSpecific mAbS Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global bi-specific mAbS market as it emerges from the COVID-19 shut down.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis


Description:
Where is the largest and fastest-growing market for bi-specific mAbS? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The bi-specific mAbS market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider bi-specific mAbS market; and compares it with other markets.

The report covers the following chapters
• Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions, and explanations about the bi-specific mAbs market.
• Key Trends
Highlights the major trends shaping the global bi-specific mAbs market. This section also highlights likely future developments in the market.
• Global Market Size and Growth
Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional Analysis
Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.
• Market Segmentation
Contains the market values (2017-2032) and analysis for each segment by type, by indication and by end use in the market.
• Regional Market Size and Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies
This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
• Conclusions And Recommendations
This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for bi-specific mAbS providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
• Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Type: Catumaxomab (Removab™); Blinatumomab; Emicizumab; Amivantamab; Faricimab; Teclistamab
2) By Indication: Cancer; Hemophilia A; Ophthalmic
3) By End Use: Hospitals; Research Institutes; Other End-Users

Companies Mentioned: F. Hoffmann-La Roche AG; Amgen Inc; Johnson & Johnson

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; bi-specific mAbS indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.



This report describes and explains the bi-specific mAbs market and covers 2017-2022, termed the historic period, and 2022-2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.

The global bi-specific mAbs market reached a value of nearly $4,462.4 million in 2022, having grown at a compound annual growth rate (CAGR) of 69.9% since 2017. The market is expected to grow from $4,462.4 million in 2022 to $11,811.0 million in 2027 at a rate of 21.5%. The market is then expected to grow at a CAGR of 13.5% from 2027 and reach $22,255.9 million in 2032.

Growth in the historic period resulted from increased healthcare expenditure, increased funding and government initiatives.

Going forward, an increasing prevalence of cancer, an increasing aging population and an increase in prevalence of chronic diseases will drive market growth. Factors that could hinder the growth of the bi-specific mAbs market in the future include the Russia-Ukraine war and the availability of various alternative treatment methods for cancer.

The bi-specific mAbs market is segmented by type into blinatumomab, emicizumab, amivantamab faricimab and teclistamab. The emicizumab market were the largest segment of the bi-specific mAbs market segmented by type accounting for 86.6% of the total in 2022. Going forward, the amivantamab market is expected to be the fastest growing segment in the bi-specific mAbs market segmented by type, at a CAGR of 44.8% during 2022-2027.

The bi-specific mAbs market is segmented by indication into cancer, hemophilia A and ophthalmic. The hemophilia A market was the largest segment of the bi-specific mAbs market segmented by indication accounting for 86.6% of the total in 2022. Going forward, the ophthalmic market is expected to be the fastest growing segment in the bi-specific mAbs market segmented by indication, at a CAGR of 46.5% during 2022-2027.

The bi-specific mAbs market is segmented by end use into hospitals, research institutes, and other end-users. The hospitals market was the largest segment of the bi-specific mAbs market segmented by end users accounting for 65.5% of the total in 2022. Going forward, the hospitals market is expected to be the fastest growing segment in the bi-specific mAbs market segmented by end users, at a CAGR of 21.9% during 2022-2027.

North America was the largest region in the bi-specific mAbs market, accounting for 62.6% of the total in 2022. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the bi-specific mAbs market will be Western Europe and Asia Pacific where growth will be at CAGRs of 17.2% and 11.5% respectively. These will be followed by the Middle East and South America where the markets are expected to grow at CAGRs of 4.2% and 2.0% respectively.

The global bi-specific mAbs market is highly concentrated, with a small number of large players constituting the majority of the market. The three competitors in the market made up to 100% of the market in 2021. Technological innovations in the recent past helped companies to strengthen their market presence. F. Hoffmann-La Roche AG was the largest competitor with 85.74% share of the market, Amgen Inc with 13.45%, and Johnson & Johnson with 0.81%.

The top opportunities in the bi-specific mAbs market segmented by type will arise in the emicizumab segment, which will gain $5,868.3 million of global annual sales by 2027. The top opportunities in segment by indication will arise in the hemophilia A segment, which will gain $5,868.3 million of global annual sales by 2027. The top opportunities in segment by end use will arise in the hospitals segment, which will gain $4,938.8 million of global annual sales by 2027. The bi-specific mAbs market size will gain the most in the USA at $3,483.4 million.

Market-trend-based strategies for the bi-specific mAbs market include focus on technological advancements, product innovation, focus on artificial intelligence, investment in targeted and combination therapy and strategic partnerships.

Player-adopted strategies in the bi-specific mAbs market include focus on enhancing business operations through securing regulatory approvals, strengthening operational capabilities through strategic acquisitions and strengthening business operations through securing regulatory approvals.

To take advantage of the opportunities, The Business Research Company recommends the bi-specific mAbs companies to focus on artificial intelligence, focus on product innovation, focus on investment in targeted and combination therapy, focus on technological advancements, expand in emerging markets, continue to focus on developed markets, expanding in countries offering research incentives, focus on strategic partnerships, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, continue to target fast-growing end-users and target the aging population.



ページTOPに戻る


Table of Contents

1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. BiSpecific mAbs Market Definition and Segmentations
6.4. Market Segmentation By Type
6.4.1. Catumaxomab (Removab™)
6.4.2. Blinatumomab
6.4.3. Emicizumab
6.4.4. Amivantamab
6.4.5. Faricimab
6.4.6. Teclistamab
6.5. Market Segmentation By Indication
6.5.1. Cancer
6.5.2. Haemophilia A
6.5.3. Ophthalmic
6.6. Market Segmentation By End Use
6.6.1. Hospitals
6.6.2. Research Institutes
6.6.3. Other End-Users
7. Major Market Trends
7.1. Technological Advancements
7.2. Product Innovation
7.3. Focus On Artificial Intelligence
7.4. Investment in Targeted and Combination Therapy
7.5. Strategic Partnerships
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
8.2.1. Market Drivers 2017 – 2022
8.2.2. Market Restraints 2017 – 2022
8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 – 2027
8.3.2. Market Restraints 2022 – 2027
9. Global BiSpecific mAbS Market Segmentation
9.1. Global BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.2. Global BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.3. Global BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. BiSpecific mAbS Market, Regional and Country Analysis
10.1. Global BiSpecific mAbS Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.2. Global BiSpecific mAbS Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.4. Asia-Pacific BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.5. Asia-Pacific BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific BiSpecific mAbS Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes levied
11.11.9. Corporate tax structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.13. China BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.14. China BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.15. China BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.16. China BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.19. India BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.20. India BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.21. India BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.22. India BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.25. Japan BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.26. Japan BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.31. Australia BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.32. Australia BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.37. Indonesia BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.38. Indonesia BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.43. South Korea BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.44. South Korea BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes levied
12.2.9. Corporate tax structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.4. Western Europe BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.5. Western Europe BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe BiSpecific mAbS Market: Country Analysis
12.9. UK Market
12.10. UK BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.11. UK BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.12. UK BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.13. UK BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.14. UK BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.17. Germany BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.18. Germany BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.23. France BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.24. France BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.25. France BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.26. France BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.4. Eastern Europe BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.5. Eastern Europe BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe BiSpecific mAbS Market: Country Analysis
13.9. Russia Market
13.10. Russia BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.11. Russia BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.12. Russia BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.4. North America BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.5. North America BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.6. North America BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.7. North America BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.8. North America BiSpecific mAbS Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.13. USA BiSpecific mAbS Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.14. USA BiSpecific mAbS Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.15. USA BiSpecific mAbS Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.16. USA BiSpecific mAbS Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.4. South America BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.5. South America BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.6. South America BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.7. South America BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.8. South America BiSpecific mAbs Market: Country Analysis
15.9. Brazil Market
15.10. Brazil BiSpecific mAbs Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.11. Brazil BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.12. Brazil BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.4. Middle East BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.5. Middle East BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa BiSpecific mAbS Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
17.4. Africa BiSpecific mAbs Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
17.5. Africa BiSpecific mAbs Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa BiSpecific mAbs Market, Segmentation By Indication, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa BiSpecific mAbs Market, Segmentation By End Use, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape and Company Profiles
19. Company Profiles
19.1. F. Hoffmann-La Roche AG
19.1.1. Company Overview
19.1.2. Products And Services
19.1.3. Business Strategy
19.1.4. Financial Overview
19.2. Amgen Inc
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. Johnson & Johnson
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
20. Key Mergers and Acquisitions
20.1. invoX Pharma Acquired F-Star Therapeutics, Inc.
20.2. Amgen Acquired TeneoBio
20.3. Sanofi Acquired Kymab Group Ltd.
20.4. AbCellera Acquired OrthoMab Bispecific Platform
20.5. True North Acquired Stake In Biocon Biologics
21. Opportunities And Strategies
21.1. Global BiSpecific mAbS Market In 2027 – Countries Offering Most New Opportunities
21.2. Global BiSpecific mAbS Market In 2027 – Segments Offering Most New Opportunities
21.3. Global BiSpecific mAbS Market In 2027 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Bi-Specific mAbs Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. The Business Research Company
23.5. Copyright and Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

The Business Research Company (TBRC)社の医薬分野での最新刊レポート


よくあるご質問


The Business Research Company (TBRC)社はどのような調査会社ですか?


The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/13 10:29

155.97 円

166.03 円

201.39 円

ページTOPに戻る